PMEL17 Antibody / Melanoma gp100
PMEL17/Melanoma gp100/SILV plays a central role in the biogenesis of melanosomes. Involved in the maturation of melanosomes from stage I to II. The transition from stage I melanosomes to stage II melanosomes involves an elongation of the vesicle, and the appearance within of distinct fibrillar structures. Release of the soluble form, ME20-S, could protect tumor cells from antibody mediated immunity. [UniProt]The gp100 molecule is a 100kDa glycosylated protein that is cleaved into a small (26kDa) carboxy-terminal fragment and a larger amino- terminal section (60-64 kDa), which is subsequently cleaved to generate 26kDa and 34-38kDa fragments.
Product Specifications
UniProt
P40967
Reactivity
Human
Immunogen
Recombinant human protein was used as the immunogen for the PMEL17 antibody.
Clonality
Monoclonal
Clone
MSSG95
Conjugation
Unconjugated
Field of Research
Cancer Biology; Cell Biology
Purification
Protein G affinity chromatography
Dilution
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Applications Notes
Tested Applications
IHC-P
Host or Source
Mouse
Preservative
Prediluted in 1X PBS, 0.1 mg/ml rAlbumin, 0.05% sodium azide; For IHC use only
Isotype
Mouse IgG1, kappa
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![(Alpha3S,Alpha3'S)-6,6'-Dibenzyloxy-Alpha3,Alpha3'-bis[[(benzyloxy)carbonyl]amino]-[1,1'-biphenyl]-3,3'-dipropanoic Acid 3,3'-Bis(benzyl) Ester](https://cdn.genprice.uk/products/572/6987701429826/imageurl/trc-d418850-1mg.webp)